Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORA520 in Severe Postpartum Depression
NCT06285916Phase 2Completed
- Sponsor
- TWi Biotechnology, Inc.
- Start
- Mar 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nora520 in postpartum depression (PPD), sponsored by TWi Biotechnology, Inc.. Started Mar 2024; status: completed.
02
Drugs
nora520
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT06285916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06285916.